Dr. Amelia Rodríguez-Aranda is the new Director of R&D and combines it with her current position as Chief Medical Officer of the Eugin Group.

Amelia has been part of Eugin since 2010, providing business advisory support and leading the group’s medical expansion into other countries. In addition to overseeing the medical area, she has played an active role in the scientific projects carried out within our group, directly contributing to studies and participating in various scientific committees, both locally and internationally. She is the co-founder of the international EBART Congress, which she has successfully led since its inception in 2016. The most recent edition, EBART 2024, marked its 5th edition with over 2,000 participants, both in person and online.

Eugin remains committed to strengthening our presence and relevance in the field of clinical research and to continuing to lead the reproductive medicine sector through research that is patient-centered and focused.

We are confident that, with Amelia’s continued leadership and focus on innovation and quality, we will keep advancing in this new stage of our journey.